
AVROBIO AVRO
Quartalsbericht 2025-Q3
hinzugefügt 06.11.2025
AVROBIO EV 2011-2026 | AVRO
EV Jährlich AVROBIO
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -35.4 M | -9.31 M | -155 M | 279 M | 394 M | 59 M | 24.2 M | 9.98 M | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 394 M | -155 M | 70.7 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AgeX Therapeutics
AGE
|
6.28 M | - | -10.17 % | $ 12.2 K | ||
|
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M | ||
|
Anika Therapeutics
ANIK
|
300 M | $ 9.46 | 1.18 % | $ 139 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-28.9 M | $ 3.25 | 2.85 % | $ 7.82 B | ||
|
AlloVir
ALVR
|
-64.1 M | - | 4.14 % | $ 49.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
10.2 B | $ 10.01 | -7.66 % | $ 647 M | ||
|
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M | ||
|
Aeglea BioTherapeutics
AGLE
|
725 M | - | - | $ 1.01 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
4.79 M | - | -18.52 % | $ 27.3 M | ||
|
Ascendis Pharma A/S
ASND
|
726 M | $ 211.38 | -0.9 % | $ 5 B | ||
|
Aclaris Therapeutics
ACRS
|
192 M | $ 2.62 | -9.2 % | $ 203 M | ||
|
AIkido Pharma
AIKI
|
22.8 M | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
417 M | - | -0.23 % | $ 916 M | ||
|
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - | ||
|
Alpine Immune Sciences
ALPN
|
363 M | - | - | $ 2.17 B | ||
|
ARCA biopharma
ABIO
|
436 M | - | 1052.0 % | $ 415 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-1.05 M | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
7.6 M | - | - | $ 10.1 M | ||
|
Acasti Pharma
ACST
|
24 M | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
2.15 B | - | -15.15 % | $ 60.3 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
647 M | $ 4.28 | -2.73 % | $ 9.31 B | ||
|
Athersys
ATHX
|
-37.4 M | - | 3.77 % | $ 22.4 M | ||
|
BioNTech SE
BNTX
|
-6.64 B | $ 96.5 | -0.2 % | $ 27.2 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
2 B | $ 26.84 | 1.42 % | $ 1.3 B | ||
|
Avenue Therapeutics
ATXI
|
-1.23 M | - | -52.27 % | $ 4.45 M | ||
|
Autolus Therapeutics plc
AUTL
|
1.11 B | $ 1.81 | -3.21 % | $ 462 M | ||
|
CASI Pharmaceuticals
CASI
|
1.08 B | $ 0.85 | 3.22 % | $ 116 M | ||
|
Catalyst Biosciences
CBIO
|
38.1 M | $ 11.08 | -0.05 % | $ 729 M | ||
|
BioDelivery Sciences International
BDSI
|
445 M | - | -4.8 % | $ 255 M | ||
|
Arena Pharmaceuticals
ARNA
|
5.65 B | - | -6.81 % | $ 3.04 B | ||
|
BeiGene, Ltd.
BGNE
|
253 B | - | 0.49 % | $ 251 B | ||
|
Acer Therapeutics
ACER
|
38.2 M | - | 2.71 % | $ 14 M | ||
|
BioVie
BIVI
|
-12.6 M | $ 1.29 | -3.01 % | $ 1.91 M | ||
|
Axon Enterprise
AXON
|
41.5 B | $ 593.03 | 5.25 % | $ 44.9 B | ||
|
Ayala Pharmaceuticals
AYLA
|
5.32 M | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-15.2 M | $ 2.9 | 4.69 % | $ 18.2 M | ||
|
AstraZeneca PLC
AZN
|
57.7 B | $ 91.04 | -0.58 % | $ 96.9 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
-9.74 M | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
115 M | - | -7.31 % | $ 87 M | ||
|
Acorda Therapeutics
ACOR
|
-13.2 M | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
515 K | - | -5.38 % | $ 6.06 M | ||
|
Burford Capital Limited
BUR
|
3.22 B | $ 9.11 | 4.35 % | $ 1.48 B | ||
|
bluebird bio
BLUE
|
270 M | - | - | $ 546 M | ||
|
Cellectis S.A.
CLLS
|
109 M | $ 4.56 | -5.1 % | $ 116 M | ||
|
Biogen
BIIB
|
28.3 B | $ 174.34 | -1.96 % | $ 25.4 B | ||
|
Cellectar Biosciences
CLRB
|
60.8 M | $ 3.39 | -2.31 % | $ 41.4 M | ||
|
Abeona Therapeutics
ABEO
|
184 M | $ 5.23 | -1.6 % | $ 112 M |